ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GEORGE CARROLL MD

Internal Medicine

163

$52.2K

47
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

81%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

94%
prescriptions for brand name drugs

Avg: 25%

$320
Average prescription price

Avg: $56

HERNANDO CARRILLO MD

Internal Medicine

169

$8,497

12
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $56

DANIEL LOGAN MD

Internal Medicine

203

$38.3K

25
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

56%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$188
Average prescription price

Avg: $56

VIOLET LAGARI-LIBHABER DO, MPH

Internal Medicine

228

$13.9K

39
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $56

TOLGA ERIM D.O.

Internal Medicine

249

$22K

99
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$88
Average prescription price

Avg: $56

MOHAMMED RAFI M.D

Internal Medicine

261

$5,745

156
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

32%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$22
Average prescription price

Avg: $56

WILLIAM STEIN MD

Internal Medicine

280

$32.6K

27
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

63%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$116
Average prescription price

Avg: $56

MARC SHAPIRO D.O.

Internal Medicine

286

$5,252

174
97 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 25%

$18
Average prescription price

Avg: $56

ALEXANDER RODI DO

Internal Medicine

288

$12.5K

129
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

39%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $56

CHRISTINE JOHNSTONE MD

Internal Medicine

306

$7,020

172
86 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$23
Average prescription price

Avg: $56

LUIS ARIAS-URDANETA M.D.

Internal Medicine

325

$20.6K

83
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

MORRIS DEES MD

Internal Medicine

329

$88.2K

74
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 25%

$268
Average prescription price

Avg: $56

MICHELLE ZETOONY NUDELL D.O.

Internal Medicine

331

$68.6K

87
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$207
Average prescription price

Avg: $56

ADAM GREENBERG MD

Internal Medicine

333

$35.9K

148
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$108
Average prescription price

Avg: $56

KRISHNA KASTURI MD

Internal Medicine

337

$16.1K

222
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $56

DANA KLEINMAN D.O.

Internal Medicine

340

$5,035

241
179 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$15
Average prescription price

Avg: $56

SERGIO CASTILLO MD

Internal Medicine

342

$5,523

241
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $56

KERRY HENDERSON MD

Internal Medicine

351

$4,542

215
117 are 65+

20%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 25%

$13
Average prescription price

Avg: $56

NKEMDILIM UZO M.D.

Internal Medicine

366

$4,858

207
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$13
Average prescription price

Avg: $56

STEPHEN KUCERA M.D.

Internal Medicine

368

$35.8K

97
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$97
Average prescription price

Avg: $56

JOSE SANTANA MD

Internal Medicine

377

$4,628

211
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

44%
patients receiving schedule three controlled substances

Avg: 8%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 25%

$12
Average prescription price

Avg: $56

LORI KIM MD

Internal Medicine

378

$183K

107
89 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$484
Average prescription price

Avg: $56

JUAN ROJAS BALCAZAR M.D.

Internal Medicine

381

$63.3K

52
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 25%

$166
Average prescription price

Avg: $56

BERNARDITA MAURE MD

Internal Medicine

387

$6,652

32
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$17
Average prescription price

Avg: $56

RONALD LEVY MD

Internal Medicine

396

$175K

129
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$442
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank